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Abstract
Alzheimer’s (AD) is a progressive neurodegenerative disease that afflicts a significant fraction of older individuals. Although
a proteolytic product of the Amyloid precursor protein, the Ab42 polypeptide, has been directly implicated in the disease,
the genes and biological pathways that are deployed during the process of Ab42 induced neurodegeneration are not well
understood and remain controversial. To identify genes and pathways that mediated Ab42 induced neurodegeneration we
took advantage of a Drosophila model for AD disease in which ectopically expressed human Ab42 polypeptide induces cell
death and tissue degeneration in the compound eye. One of the genes identified in our genetic screen is Toll (Tl). It encodes
the receptor for the highly conserved TlRNFkB innate immunity/inflammatory pathway and is a fly homolog of the
mammalian Interleukin-1 (Ilk-1) receptor. We found that Tl loss-of-function mutations dominantly suppress the
neuropathological effects of the Ab42 polypeptide while gain-of-function mutations that increase receptor activity
dominantly enhance them. Furthermore, we present evidence demonstrating that Tl and key downstream components of
the innate immunity/inflammatory pathway play a central role in mediating the neuropathological activities of Ab42. We
show that the deleterious effects of Ab42 can be suppressed by genetic manipulations of the TlRNFkB pathway that
downregulate signal transduction. Conversely, manipulations that upregulate signal transduction exacerbate the
deleterious effects of Ab42. Since postmortem studies have shown that the Ilk-1RNFkB innate immunity pathway is
substantially upregulated in the brains of AD patients, the demonstration that the TlRNFkB signaling actively promotes the
process of Ab42 induced cell death and tissue degeneration in flies points to possible therapeutic targets and strategies.
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Introduction
Although the neurodegenerative Alzheimer’s disease (AD) is
usually associated with the aging process, mutations in a number
of different genes have been correlated with a familial, early onset
of the dementia [1–5]. The first AD-related mutations identified
were in the amyloid b precursor protein (APP), a type I integral
membrane protein [3–6]. The APP protein is a precursor for a 42
residue proteolytic cleavage product, Ab42, that accumulates in
large aggregates or plaques in the brains of Alzheimer’s patients.
Mutations in the APP protein which are associated with early
onset of AD increase the production of Ab42 polypeptide or its
tendency to form aggregates [7–10]. The connection between APP
and, in particular, the Ab42 polypeptide and AD was further
strengthened by the finding that mutations in presenlin, a protease
involved in the processing of the APP protein, are also associated
with familial early onset AD [11–14]. These mutations are thought
to increase the amount of Ab42 polypeptide produced relative to
another non-toxic APP cleavage product, the Ab40 polypeptide.
While these observations have implicated Ab42 in AD, how this
polypeptide induces neurodegeneration remains uncertain. The
brains of individuals with AD are characterized by large plaques of
aggregated Ab42 protein, neurofibrillary tangles composed of
hyperphosphorylated Tau protein, and the loss of a significant
fraction of the neurons in the hippocampus, prefrontal and
entorhinal cortex [15–19]. Initially it was thought that the
aggregated Ab42 containing amyloid plaques induced the
neurofibrillary tangles and neurodegeneration. However, the
connection between large amyloid plaques and AD is unlikely to
be direct as the correlation between the extent of plaque formation
and either the severity of dementia or the loss of neurons is poor.
Instead, recent studies have suggested that the large plaques may
actually be relatively inert and that smaller oligomers of the Ab42
polypeptide correspond to the primary neurotoxic agent for AD
[20–22].
If the Ab42 polypeptide is a causative agent for AD, it is
important to understand what biological pathways are targeted by
the polypeptide and how these pathways are deployed to produce
the neuropathological phenotypes associated with the disease.
With this aim in mind several laboratories have independently
developed Alzheimer’s models in the fruit fly Drosophila [23–26].
Ectopic expression of human Ab42 polypeptide in the CNS of the
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progressive decline in locomotor function, age-dependent learning
defects, progressive neurodegeneration and loss of neurons and a
significant reduction in lifespan. The expression of this protein was
accompanied by the formation of diffuse amyloid deposits that
seemed to be composed primarily of Ab42 oligomers in younger
animals, while in older animals small AD-like plaques. Further
supporting the potential value of this Drosophila model for human
AD, the deleterious effects of the Ab polypeptide are specific to the
Ab42 isoform. Thus, unlike Ab42, ectopic expression of the human
Ab40 polypeptide did not disrupt locomotor function or alter the
lifespan, nor did it appear to induce neurodegeneration [26].
The neuropathological effects of the human Ab42 polypeptide
are not limited to the CNS. When Ab42 is expressed in the eye it
causes cell death and tissue degeneration [25,26]. This disrupts the
stereotypic and repeating morphology of the lens and gives a
readily visible rough eye phenotype that worsens with age. Within
a single transgenic line the severity of the rough eye phenotype is
quite similar amongst flies of the same age; however, the
phenotype depends upon the level of expression of the transgene
insert and some inserts have only mild effects on eye development
while others have moderate or even severe effects. Since the rough
eye phenotype is sensitive to changes in Ab42 activity it is well
suited for identifying genes that modify the pathological effects of
the Ab42 polypeptide. This phenotypic assay has been used to
screen a collection of nearly 2,000 EP transposon strains for
insertions that alter the Ab42-induced rough eye phenotype. The
EP transposon has a GAL4 activated promoter and, depending
upon the site and orientation of the insertion, it will upregulate
gene activity, have no effect, or downregulate gene activity.
Altogether 23 lines that modified the rough eye phenotype were
recovered in the EP screen. The interacting EP insertions were
found to be located in genes involved in secretion, cholesterol
homeostatis, the innate immune pathway and chromatin organi-
zation [27].
As a complementary approach for elucidating the genes and
pathways that mediate the neurodegenerative effects of the Ab42
polypeptide, we have screened for second site loss-of-function
mutations that dominantly enhance or suppress the degeneration
of the eye induced by the Ab42 polypeptide. To identify genes
important for Ab42 neuropathology we first screened the
Bloomington stock center 2
nd and 3
rd chromosome deficiency kit
for interacting deletions. We then pinpointed the locus responsible
for modifying the rough eye phenotype by testing mutations in
genes that are included in the deficiency. One of the suppressing
deficiencies uncovered the Drosophila Toll (Tl) gene. Toll encodes a
transmembrane receptor which has a leucine rich extracellular
domain and intracellular signaling domain that is closely related to
the mammalian Interleukin-1 receptor [28–31]. The Tl gene was
first identified in maternal effect screens because of its role in
establishing the dorsal-ventral (D-V) polarity axis of the embryo
[32,33]. In D-V polarity, binding of Spatzle ligand to the Toll
extracellular domain activates a cytoplasmic signaling cascade
[34]. This cascade promotes the nuclear translocation of two
NFkB-like transcription factors, Dorsal and Dif, which function to
specify ventral cell fate in blastoderm stage embryo [35–36].
Subsequent work demonstrated that in addition to its role in
embryonic polarity, the Tl receptorRNFkB signal transduction
pathway is deployed, just as it is in mammals, in the innate
immunity and inflammatory pathways of the fly [28–31,38–40].
In the studies reported here we show that the TlRNFkB innate
immunity-inflammatory pathway plays a central role in orches-
trating the neuropathological activities of the human Ab42
polypeptide in flies. Our findings support emerging models for
AD and other forms of neurodegenerative diseases in humans in
which the inflammatory response acts as a critical catalyst in
promoting the process of neurodegeneration.
Results
Reducing Tl activity ameliorates the neuropathological
effects of the Ab42 polypeptide on eye development
Ectopic expression of Ab42 in the developing eye using the
Glass Multimer Reporter, pGMR, induces a rough eye phenotype
[25,26]. This phenotype can be used to screen for interacting
genes that mediate the neurodegenerative effects of the Ab42
polypetide on the Drosophila eye. Since we wished to identify
mutations in genes that can either ameliorate or potentiate the
effects of the Ab42 polypeptide, we selected a pGMR:Ab42
insertion that has a moderate rough eye phenotype (Fig. 1A). We
used this insert to screen the Fly Center collection of 2
nd and 3
rd
chromosome deficiencies (which is thought to account for ,60%
of fly genes) for deletions that dominantly (Df/+) suppress or
enhance the Ab42 eye phenotype. Of the 130 deficiencies tested,
we identified 14 strong or moderate suppressors and 9 strong or
moderate enhancers.
One of the strong suppressors was Df(3)T1-P which uncovers
the cytological interval 97A-98A on the right arm of the 3
rd
chromosome. To further narrow down the chromosomal DNA
segment that contains the interacting gene(s) we tested five
deficiencies that overlap Df(3)T1-P–Df (3)Tl-l (97B-97E),
Df(3R)T1-X (97B-97D1,2), Df(3R)ED6235 (97B9-97D1,2),
Df(3R)ro80b (97D1-D13) and Df(3R)ME61 (96F1,2-97C5). All
but Df(3R)ME61 ameliorated the rough eye phenotype and taken
together these findings map the suppressor to the 97D interval.
To identify the suppressor we next tested mutations in genes
that are known to be located in this chromosomal interval. One
of the genes that is included in the 97D and is deleted in all of
the suppressing deficiencies is Tl. This gene was the most
plausible candidate as one of the EP transposons uncovered in
the previous screen is inserted into the Tl gene [27]. Tl encodes a
highly conserved type I transmembrane receptor that shares
extensive homology with vertebrate receptors for the cytokines
interleukin-1 (IL-1) and interleukin 18 (IL-18) [29,41,42]. In flies
and vertebrates the Toll-like receptors are components of the
innate immune response/inflammatory pathway that control the
nuclear localization of transcription factors in the NFkB family
[41–45].
The first Tl mutation we tested, Tl
r4, is an ethylmethanesulfo-
nate (EMS) induced allele. It is a hypomorphic mutation that has
two amino acid substitutions in the extracellular domain of the
receptor [46]. As shown in Fig. 1B and Table 1, Tl
r4 strongly
suppresses the rough eye phenotype induced by ectopic Ab42.
While this result suggested that Tl corresponds to the interacting
locus, we wanted to exclude possible effects of genetic background.
Thus to confirm the identity of the suppressor we tested three
other Tl loss-of-function alleles. The first is a temperature sensitive
EMS induced allele, Tl
r3. The second and third are the transposon
induced mutations, Tl
KG03609 and Tl
rK343. The former is inserted
into the 59 UTR, while the latter is inserted into a large intron.
Like the two EMS alleles, these insertions are hypomorphic. As
shown in Fig. 1C–E (and Table 1), all three of these mutations also
suppress the Ab42 induced rough eye phenotype. Tl
r3 and
Tl
KG03609 are weak suppressors, while suppression by Tl
rK343 is
almost as strong as that observed for Tl
r4. The differences in the
extent of suppression between these hypomorphic Tl alleles are
likely to be due to a combination of both the strength of the
mutation and differences in their genetic backgrounds.
TollRNFkB Signaling and AD
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The finding that several independent loss-of-function mutations
in Tl dominantly suppress the rough eye phenotype induced by
ectopic Ab42 is intriguing as connections between AD and
canonical mammalian innate immunity/inflammatory pathways
have been extensively documented in the literature [45–49].
However, while these studies clearly demonstrate that the
inflammatory pathways are activated in the brains of AD patients,
it is not clear from this correlation whether the deployment of these
pathways actively promotes the process of neurodegeneration or
whether they are functioning instead to retard the progression of the
disease [47–52]. Thus, it would be important to determine whether
there is actually a causal relationship between the activation of the
fly TlRNFkB innate immunity/inflammatory pathway and the
disruptive effects of Ab42 on eye development.
If the fly TlRNFkB signaling pathway functions to actively
promote the neuropathological effects of Ab42, then excess Tl
activity would be expected to exacerbate the Ab42 induced rough
eye phenotype. Consistent with this prediction, the transposon
insertion in Tl identified in the EP screen strongly enhances the
rough eye phenotype. Since the transposon upregultates Tl mRNA
by nearly 5 fold, this would be expected to substantially increase the
amount of Tlprotein. On the other hand,while elevated levelsof the
receptor should potentiate signal transduction, we cannot exclude
the possibility that Ab42 or some side product induces neurodegen-
eration by some type of interaction with Tl that does not involve an
activation of the receptor. To test this possibility we combined the
pGMR-Ab42 transgene with a gain-of-function Tl allele, Tl
3.T h i s
allele has an amino acid substitution in the extracellular domain that
leads to constitutive signaling by the Tl receptor independent of
ligand [31,45]. As shown in Fig. 1F (and Table 1) excess Tl signaling
enhances the neuropathological effects of the Ab42 polypeptide.
Neuropathological effects of Ab42 are mediated by the Tl
signaling pathway
The effects of reducing and increasing Tl activity would be
consistent with the idea that the fly TlRNFkB signaling pathway
plays an instrumental role in promoting Ab42 induced cell death
and tissue degeneration in the eye. This hypothesis makes two
strong predictions. The first is that the severity of the Ab42 rough
eye phenotype will be sensitive to the activity of other components
of the TlRNFkB signaling pathway. The second is that genetic
manipulations which lead to an upregulation of TlRNFkB signal
transduction will tend to exacerbate the rough eye phenotype,
while manipulations that downregulate signal transduction will
tend ameliorate the phenotype.
As shown in Fig. 2, a circulating peptide, Spatzle, which is
activated by proteolysis binds to the Tl receptor and turns on the
cytoplasmic signaling cascade [28–31,33]. Signal transduction
Table 1. Tl amd dl mediate the Ab42 induced rough eye
phenotype.
Ab42/+ ++++
Ab42/Tl
r4 +
Ab42/Tl
r3 +++
Ab42/Tl
KG03609 +++
Ab42/Tl
rk343 ++
Ab42/Tl
3 ++++++
Ab42/dl
1 ++/+++
Ab42/dl
4 ++
Ab42/dl
8 ++/+++
Ab42/hsp83:dl ++++++
The rough eye phenotype of pGMR-Ab42 flies was assigned a value of ++++.
According to this scoring system, strong, moderate and weak suppression
corresponded to +, ++,a n d+++ respectively. Weak and moderate enhancement
corresponded to +++++ and ++++++. All flies are hemizygous for the transgene
and either wild type (+) or heterozygous for the indicated mutation. In the
experiment with the hsp83:dl transgene the flies are hemizygous for this
transgene.
doi:10.1371/journal.pone.0003966.t001
Figure 1. Ab42 induced rough eye phenotype is sensitive to Toll activity. WT: Wild type flies. Ab: pGMR-Ab42 transgenic flies. In the
experiments shown in this figure, the flies are hemizygous for the pGMR-Ab42 transgene. Panel A: WT: eye of a wild type fly. Ab/+: eye of a wild type
fly hemizygous for the pGMR-Ab42 transgene. Panels B through F show sibling pGMR-Ab42 transgene flies that are either wild type Tl or
heterozygous for the indicated Tl allele. Panel B: Ab/+: hemizygous for the Ab transgene; Ab/Tl
r4: heterozygous for the LOF allele Tl
r4. Panel C: Ab/+:
hemizygous for the Ab transgene; Ab/Tl
r3: heterozygous for the LOF allele Tl
r4. Panel D: Ab/+: hemizygous for the Ab transgene; Ab/Tl
KG: heterozygous
for the LOF allele Tl
KG03609. Panel E: Ab/+: hemizygous for the Ab transgene; Ab/Tl
rk: heterozygous for the LOF allele Tl
rK343. Panel F: Ab/+: hemizygous
for the Ab transgene; Ab/Tl
3: heterozygous for the GOF allele Tl
r3.
doi:10.1371/journal.pone.0003966.g001
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kinase Pelle (Pll). The target for the Pll kinase is the fly IkB
homolog Cactus (Cact). In the absence of signaling, the Cact
protein binds to the NFkB family transcription factors Dl and Dif
and retains them in the cytoplasm. Phosphorylation of Cact by Pll
is thought to target Cact for degradation, and this releases Dl and
Dif for nuclear translocation and regulation of their target genes.
--dl: The function of the Tl signal transduction cascade in the
innate immune response is to promote the nuclear translocation of
the Dl and Dif transcription factors [28–31]. These two NFkB
family members are thought to exist as Dl:Dl and Dif:Dif
homodimers and Dl:Dif heterodimers. Studies by Han and Ip
[53] have suggested that the homo and heterodimers regulate
different sets of genes and consequently either one or both of these
NFkB transcription factors could be the relevant target for the Tl
pathway in Ab42 induced neuropathology.
If the Tl dependent nuclear translocation of Dl promotes the
neuropathological effects of Ab42 then reducing the activity of this
transcription factor would be expected to suppress the rough eye
phenotype. We tested three different dl alleles dl
1, dl
4 and dl
8 for
genetic interactions with the pGMR-Ab42 transgene as heterozy-
gotes. As shown in Fig. 3 and Table 1, dl
4 is a moderate
suppressor, while the two other dl alleles are moderate to weak
suppressors.
The disruptions in eye development induced by the Ab42
polypetide are dose sensitive and can be greatly enhanced when
there are two copies of the pGMR-Ab42 transgene. Unlike the
hemizygotes (see Figs 1 & 3), the eyes of homozygous flies are
smaller in size and instead of a regular repeating hexagonal array
of ommatidia, the surviving ommatidia are highly disorganized
and have a blistered and very glossy morphology (see Ab/Ab eyes
in Fig. 4). We reasoned that if the TlRdl pathway is a key player in
Ab42 induced neurodegeneration, then it would be possible to
ameliorate even this much more severe disruption in eye
development by reducing dl activity. This is the case. In fact, we
found that reducing the dose of the dl gene from 2 to 1 wild type
copy strongly suppresses the neuropathological effects of the Ab42
polypeptide. This was observed not only for the moderate
suppressor, dl
4, but also for both of the weaker suppressors dl
1
and dl
8 (Fig. 4). In all three cases, the eye of the pGMR-Ab42/
pGMR-Ab42; dl/+ fly is nearly wild type in size. Moreover,
instead of the very rough and glossy eye morphology evident in the
Ab42 homozygotes, the ommatidia of the dl/+ flies are arranged in
a considerably more regular and repeating hexagonal array across
most of the eye. Suppression is not, however, complete and the eye
morphology is not like wild type. For example, there are many
speckles scattered across the dl
1/+ eye shown in Fig. 3A (see
arrows) which correspond to ommatidia that have dead or dying
cells. Similarly, though the ommatidia in the dl
2/+ flies shown in
Fig. 3B & C have a much more regular organization than their dl
+
sibs, the surface of the eye still appears rough and glossy.
To further confirm that the TRdl pathway actively promotes
the deleterious effects of the Ab42 polypeptide, we generated
pGMR-Ab42/pGMR-Ab42 trangenic flies that are also homozy-
gous for the dl
1, dl
4,o rdl
8 mutations. The severe disruptions in eye
development induced by high levels of Ab42 are strongly
suppressed in flies that lack dl activity. This is shown for dl
1 and
dl
4 in Fig. 4D and E. As can be seen in these panels, the eyes of the
Figure 3. Components of the Toll-NFkB signaling pathway modulate Ab42 polypetide induced neurodegeneration. Panels A–F: In the
experiments shown in this figure all flies are siblings that are hemizygous for the pGMR-Ab42 transgene. The fly on the left side of each panel is a wild
type sib, while the fly on the right side of each panel is a sib that is heterozygous for the indicated mutation in the Toll-NFkB signaling pathway
mutant. Panel A: dl
1. Panel B: dl
4. Panel C: dl
8. Panel D: pll
2. Panel E: pll
7. Panel F: tub.
doi:10.1371/journal.pone.0003966.g003
Figure 2. The Drosophila TollRDorsal/Dif and mammalian
Interleukin ReceptorRNFkB innate immunity pathways. Dia-
gram of the TlRNFkB signaling pathways in Drosophila and mammals.
See text for details.
doi:10.1371/journal.pone.0003966.g002
TollRNFkB Signaling and AD
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or glossy morphology that is seen in transgenic animals that still
have a single wild copy of the dl gene. On the other hand, the eyes
are not quite wild type and there are still some ommatidia that
have a few dead or dying cells (see arrows). As might be expected,
essentially complete suppression of the rough eye phenotype is
observed in homogyzous dl mutants when there is only a single
copy of the pGMR-Ab42 transgene. As illustrated in Fig. 4F for
the dl
1 allele, the eyes of hemizygous transgenic flies that are
homozygous mutant for dl are essentially indistinguishable from
wild type.
If reducing dl activity suppresses the neuropathological effects of
the Ab42 polypeptide, then increasing dl activity might be expect
to enhance its effects. To test this possibility we introduced an
hsp83:dl transgene into flies carrying the pGMR-Ab42 transgene.
As shown in Table 2, we found that ectopic dl enhanced the Ab42
rough eye phenotype.
--dif: Since Dif:Dl heterodimers and Dif:Dif homodimers are
also thought to mediate the Tl-dependent innate immune response
pathway, but regulate different target genes than Dl:Dl homodi-
mers, it was of interest to test whether reducing dif activity also
suppressed the Ab42 rough eye phenotype. Consistent with the
idea that dif is also an important Tl target in Ab42 induced
neurodegeneration we found dif
1 is a weak suppressor (Table 1).
--tub and pll: The tub and pll gene products function inside the
cell and are required for signal transduction by the Tl receptor.
We tested tub
2 which is thought to be amorphic allele. As shown in
Fig. 2F (and Table 1), this mutation is a moderate suppressor of
the Ab42 rough eye phenotype. We also tested two pll alleles, pll
2
and pll
7. The former is a weak to moderate suppressor, while the
latter is a moderate suppressor (Fig 2D & E and Table 2). Thus, as
would be predicted if the TlRNFkB pathway functions to
promote the neuropathological effects of the Ab42 polypetide,
reducing the activity of tub and pll suppresses the rough eye
phenotype.
Since the reduction in tub and pll acitivty in these mutants is at
most only 2-fold, it seemed possible that this would not
downregulate Tl signaling sufficiently to have a strong effect on
the Ab42 rough phenotype. For this reason, we took advantage of
a recombinant chromosome that carries mutations in both tub and
pll. As shown in Table 2, when the pGMR-Ab42 transgene is
introduced into tub pll/++ flies, the rough eye phenotype is strongly
suppressed.
--spz: We tested three alleles of the spz ligand, spz
2, spz
3, and
spz
KG05402. These spz mutations had no apparent effect on the
rough eye phenotype as heterozygotes (not shown). In this case the
failure to detect a genetic interaction could indicate that some
other ligand is required to activate the Tl receptor in this instance.
There are several other spz-like genes in Drosophila that could
potentially perform this function [31]. On the other hand, this
assay may demand that a two-fold reduction in gene dose alter the
activity of the pathway to an extent sufficient to modify the rough
eye phenotype. Thus, it also is possible that spz is not
haploinsufficient.
relish and imd: Flies have a second innate immune response
pathway that is dependent upon the Imd receptor rather than the
Tl receptor. We tested 4 mutations in the imd receptor but did not
observe any obvious alteration in the Ab42 rough eye phenotype
(not shown). The Imd pathway regulates the nuclear import of the
third fly NFkB-like transcription factor Relish (Rel). We also tested
four different rel alleles, and like imd there was no apparent
alteration in the eye phenotype when rel activity was reduced.
While these findings could indicate that the neuropathological
Table 2. Effect of mutations in the TlRNFkB pathway on the
Ab42 induced rough eye phenotype.
Ab42/+ ++++
Ab42/dif
1 +++
Ab42/tub
2 ++
Ab42/pll
2 ++/+++
Ab42/pll
7 ++
Ab42/tub pll +
The rough eye phenotype of pGMR-Ab42 flies was assigned a value of ++++.
According to this scoring system, strong, moderate and weak suppression
corresponded to +, ++,a n d+++. Weak and moderate enhancement
corresponded to +++++ and ++++++. All flies are hemizygous for the transgene
and either wild type (+) or heterozygous for the indicated mutation.
doi:10.1371/journal.pone.0003966.t002
Figure 4. Dorsal mediates Ab42 dependent neurodegeneration of the eye. Panels A–E: In the experiments shown in this figure all flies are
siblings that are homozygous for the pGMR-Ab42 transgene. The fly on the left side of each panel is a wild type sib, while the fly on the right side of
each panel is a sib that is either heterozygous or homozygous for the indicated dl mutation. Panel A: dl
1/+. Panel B: dl
4/+ Panel C: dl
8/+ Panel D: dl
1/
dl
1. Panel E: dl
4/dl
4. Panel F: In this experiment both flies are hemizygous for the pGMR-Ab42 transgene. The fly on the left is wild type, while the fly on
the right is homozygous dl
`
. Arrows in panels A and E point to ommatidia with dead or dying cells.
doi:10.1371/journal.pone.0003966.g004
TollRNFkB Signaling and AD
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immunity pathway, it is also possible that imd and rel are not
haploinsufficient in this assay.
Ab42 upregulates Cact expression in fly heads
In vertebrates one of the genes that is upregulated by the
inflammatory response is IkB which is responsible for retaining
NFkB in the cytoplasm [54]. This is also true in flies where
activation of the Tl pathway following microbial infection is found
to induce the expression of the fly IkB homolog Cact [55,56]. Our
results would argue that ectopic Ab42 must also activate the
TlRNFkB innate immune response pathway. If this supposition is
correct, then the expression of the fly IkB homolog Cact should be
upregulated by Ab42. To test this prediction we compared Cact
protein accumulation in head extracts prepared from pooled
samples of either 10 wild type flies or 10 transgenic flies that carry
two copies of the pGMR-Ab42 transgene. In wild type flies, only
low levels of Cact protein are detected in head extracts. However,
as evident from inspection of the two independent experiments
shown in Fig. 5A, there is substantial increase in the levels of Cact
protein in the heads of pGMR-Ab42 flies compared to the wild
type controls.
We wondered whether the induction of the inflammatory
response by ectopic Ab42 is stochastic and is upregulated in only
subset of the flies, or whether most flies exhibit a similar reaction to
the Ab42 polypeptide. To investigate this question, we examined
Cact expression in heads from individual wild type and Ab42
transgene flies. The experiment in Fig. 5B shows Cact protein
accumulation in heads from three wild flies and from six flies
carrying two copies of pGMR-Ab42 transgene. Cact protein levels
are elevated compared to wild type in heads from five of the six
transgenic flies. Altogether we examined Cact expression in heads
from 22 wild type flies and 18 pGMR-Ab42/pGMR-Ab42 flies. In
all of the wild type flies we observed only low levels of Cact protein
comparable to the three examples shown in Fig. 5B. By contrast,
Cact protein levels were elevated to an extent similar to that seen
in the examples shown in Fig. 5B in 17 of the 18 transgenic flies. In
other experiments we tested whether another marker for the
induction of the inflammatory response, Dorsal, was also
upregulated in the heads of pGMR-Ab42/pGMR-Ab42 flies.
Elevated levels of Dl were observed in the heads of the 5 flies that
were tested (data not shown).
While these findings indicate that the inflammatory response is
consistently activated by ectopic Ab42, it seemed possible that the
efficiency or extent of induction would depend upon the dose of
the Ab42 protein. To address this question we examined Cact
expression in the heads of transgenic flies that were hemizygous
rather than homozygous for the pGMR-Ab42 transgene. As might
be expected if induction of the inflammatory response depends
upon the dose of the Ab42 protein, we found that only 13 of the 18
head extracts examined had higher levels of Cact protein than the
wild type controls. We also noted that the level of Cact protein in
the pGMR-Ab42 hemizygotes did not appear to be as high as in
the flies homozygous for the pGMR-Ab42 transgene (not shown).
Tl signaling pathway and life span
The age dependent neurodegeneration induced by ectopic
expression of Ab42 in the CNS using an elav-GAL4 driver results in
learning deficits, climbing disabilities and a shortened life span in
adult flies [26]. Since the deleterious effects of ectopic Ab42 in the
eye are dependent upon activation of the Tl pathway, we
wondered whether this was also true in the CNS. To address
this question we asked whether modulating the activity of the Tl
signaling pathway alters the life span defects observed in Ab42
flies.
As previously reported, flies carrying both the Ab42 transgene
and the elav-GAL4 driver had a shorter average (50% survival at
,19 days) lifespan than the elva-GAL4 driver control (50% survival
at ,31 days) (see Fig. 6). We tested 3 different Tl loss of function
alleles, Tl
r4, Tl
r3 and Tl
KG03609. In the eye assay Tl
r4 was a strong
suppressor, while Tl
r3 and Tl
KG03609 were both weak suppressors.
As shown in Fig. 6, we found that the life span of the UAS-Ab42/
elav-GAL4 flies was extended by the Tl
r4 mutation (50% survival at
26 days). On the other hand, little if any effect on life span was
observed for the two other Tl alleles, Tl
r3 and Tl
KG03609. In both
cases, the life span was extended by only a few days (or about a
10% increase). We also tested whether mutations in either tub or pll
dominantly suppressed the Ab42 induced life span defects. As was
the case for the two weaker Tl alleles, tub and pll mutations had
little effect, extending the average life span (50% surviving) by at
most a 2–3 days.
Discussion
While it has been known for more than two decades that there is
a global upregulation of the inflammatory and innate immunity
pathways in the brains of AD patients, it has not been clear what
role, if any, the inflammatory response plays in AD neurodegen-
eration [46–51]. Over the years a number of findings have raised
the possibility that the inflammatory response plays an active role
in promoting neurodegeneration. One of the first indications that
it could contribute to disease progression came from epidemio-
logical studies indicating that prolonged treatment with anti-
inflammatory drugs is correlated with a reduced risk of developing
AD [57–59]. Experiments using either mammalian tissue culture
cell or whole organism AD models have also pointed to a
connection between Ab induced neurodegeneration and activation
Figure 5. Cactus protein expression is induced by the Ab42 polypeptide. Panel A. Extracts were prepared from the heads of 10 wild type
flies (WT) or 10 flies that are homozygous for the pGMR-Ab42 transgene (Ab). After gel electrophoresis and blotting, the blots were probed with
Cactus and Snf (Sans fille—the fly U1A/U2B0 snRNP protein) antibodies. The upper panel is Cactus, while the lower panel is the Snf loading control.
Two independent experiments are shown. Quantitation indicates that the level of Cactus protein is about 3.5–5 fold higher in the heads of flies
carrying the transgene. Panel B. Extracts were prepared from heads of single wild type or pGMR-Ab42 transgenic flies. After gel electrophoresis and
blotting the blots were probed with Cactus (and Snf: not shown) antibodies. Quantitation indicates that the level of Cactus protein in heads of
individual transgenic flies was between 3–8 fold higher than in wild type.
doi:10.1371/journal.pone.0003966.g005
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that expression of the cytokines IL-1, IL-6 and TNF-a are
upregulated by the human Ab peptide and that induction of these
cytokines both by Ab and by other mechanisms can have
deleterious effects on neuronal cell viability and cognition.
Moreover, downregulation of the innate immune response
pathway in a mouse AD model by treatment with anti-
inflammatory drugs or disruption of the tumor necrosis factor
death receptor gene was found to ameliorate the effects of ectopic
Ab [59,62–4]. On the other hand, not all findings have been
consistent with the notion that the inflammatory response/innate
immunity pathways promote neurodegeneration. In fact, a
number of reports have suggested instead that these pathways
play a beneficial rather than deleterious role [48,49,52]. Thus, it is
not clear at this point whether inflammation is a causative agent in
the process of neurodegeneration, is an essentially benign response
to AD, or is actually beneficial and acts to retard the progression of
the disease [52].
The findings reported here strongly support the hypothesis that
the TlRNFkB innate immunity pathway plays a critical role in
mediating the neuropathological effects of the human Ab42
polypeptide. We identified this pathway in an unbiased genetic
screen for mutations that either promote or suppress the
neurpathological effects of the Ab42 polypeptide on the Drosophila
eye. One of the suppressors recovered in our genetic screen was
the Tl receptor, which is a key component of the fly innate
immunity pathway.
Several lines of evidence demonstrate a direct connection
between the neuropathological effects of Ab42 and the activation
of the TlRNFkB signaling cascade. First, the Ab42 polypeptide
induces the accumulation of one of the well known downstream
transcriptional targets of the TlRNFkB pathway, the fly IkB
homolog cact. We also found that the levels of the fly NFkB protein
Dl are upregulated in pGMR-Ab42 transgenic flies as well. Thus,
the response of flies to the neurotoxic effects of the Ab42
polypeptide appears to mimic the upregulation of the inflamma-
tory pathways evident in both AD patients and in mouse AD
models [47–49,59–63]. Moreover, the extent of cact induction
depends upon the dose of the Ab42 polypeptide. In flies carrying
two copies of the pGMR-Ab42 transgene cact accumulation is
substantially elevated in virtually every fly. By contrast, in flies
carrying only a single pGMR-Ab42 transgene there is typically a
smaller increase in the level of the Cact protein, and in a subset of
the transgenic flies little change in Cact accumulation is evident.
Second, as would be predicted if activation of the inflammatory
response mediates the neuropathological effects of the Ab42
polypeptide, we found that loss-of-function mutations in Tl
dominantly suppress neurodegeneration of the eye induced by
ectopic Ab42. Conversely, a Tl gain-of-function allele that signals
constitutively independent of ligand exacerbates the degenerative
effects of Ab42. In this context, it is interesting to note that Tl was
identified in the screen of EP insertions [27]. The Tl insertion was
found to be a strong enhancer of Ab42 induced degeneration of the
eye and it substantially upregulates the expression of Tl mRNA.
Thus, it is possible to enhance the sensitivity of the fly to the
pathological effects ofAb42 not only by increasing the activityof the
Tl receptor, but also by increasing the amount of the receptor.
Third, Ab42 induced neurodegeneration is mediated by the
downstream target for the TlRNFkB signaling cascade, the dl
transcription factor. This is most clearly demonstrated in pGMR-
Ab42 flies that are homozygous for dl mutations. When there is
only a single copy of the transgene, suppression of the Ab42 rough
eye phenotype by the dl mutation is nearly complete and the eyes
resemble wild type. Degeneration of the eye is dependent on the
Figure 6. Reducing Tl activity partially ameliorates the reduction in lifespan induced by expressing the Ab42 polypeptide in the
CNS. Filled circles: UAS:Ab42/elav-GAL4 transgenic flies. Open boxes: UAS:Ab42/elav-GAL4 transgene flies heterozygous for Tl
4. Ovals: elav-GAL4
transgenic flies. Statistical tests using the Log Rank and Wilcoxon tests from the Lifetest Procedure both gave a Chi-Square of ,0.0001 for the
difference between the life span of UAS:Ab42/elav-GAL4 flies and of UAS:Ab42/elav-GAL4; Tl
4/+ flies. Though small differences in life span (2–3 days or
about 10%) were observed for two other Tl mutations and for mutations in tub and pll, the sample size was not large enough to be statistically
significant.
doi:10.1371/journal.pone.0003966.g006
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are two copies of the pGMR-Ab42 transgene. However, even in
this case strong suppression is observed when the transgenic flies
are homozygous for a dl loss of function mutation. Moreover, this
is not due to genetic background as three independent dl alleles
substantially reduce the much more extreme neuropathological
effects produced by two copies of the pGMR-Ab42 transgene. The
effects of dl are not limited to homozygous mutant flies; we also
found that the pGMR-Ab42 induced disruptions in eye develop-
ment are suppressed when the flies are heterozygous for a dl
mutation. In this case, suppression is less complete than that
observed in flies that are homozygous for the same dl mutation.
Fourth, like Tl and dl, mutations in three other components of
the TlRNFkB signaling cascade, tub, pll and the partner of the dl
transcription factor, dif also dominantly suppress the degenerative
effects of Ab42 on eye development. In addition, one of the
chromatin modifiers recovered in the EP screen, Dsp1, functions
as a Dl dependent co-repressor [27,65]. It should be noted that not
all genes in the TlRNFkB signaling cascade show dominant
genetic interactions with pGMR-Ab42. We tested three different
mutations in the Tl ligand spz; however, no alterations in the rough
eye phenotype were observed. Similarly no effects were observed
with a mutation in either cact or the adaptor protein myd88. Since
both cact and myd88 are thought to be canonical cell autonomous
components of the TlRNFkB signaling pathway a plausible
explanation is that these genes are not haploinsufficient in the eye
assay. In the case of spz we cannot exclude the possibility that some
other effector molecule mediates the activation of the TlRNFkB
pathway.
While our results clearly demonstrate that the TlRNFkB
pathway plays a key role in facilitating the degenerative effects of
the Ab42 polypeptide on the eye, the evidence that it also mediates
the Ab42-dependent reduction in life span is less clear cut. The Tl
allele that is the strongest suppressor in the eye assay, Tl
r4, appears
to extend the life span of UAS-Ab42/elav-GAL4 flies by about a
quarter. However, much more modest effects, if any, were
observed for two other Tl alleles, as well as for mutations in tub
and pll. Several factors could explain why these other mutations
didn’t greatly extend the life span. For one, it is possible that the
mutations we tested do not sufficiently reduce the overall activity
of the TlRNFkB signaling pathway as heterozygotes to have
much of an impact on the average life span of the UAS-Ab42/elav-
GAL4 flies. Both of the Tl alleles are hypomorphs and neither was
a strong suppressor in the eye assay. This is also true for the tub
and pll mutations. Given the very strong suppression of the rough
eye phenotype observed pGMR- Ab42 flies that are homozygous
for dl mutations, it is possible that we would observe a significant
suppression of the life span defects in mutants that lack tub or pll
altogether. Another difference is that the life span assay is likely to
be a much more indirect measure of the degenerative effects of the
Ab42 polypeptide. While the deleterious effects of the Ab42
polypeptide on individual cells in each ommatidia can be observed
directly, life span depends upon a complex combination of genetic
background, environmental conditions and chance circumstances
and the neurodegeneration induced by Ab42 is just one element
among many that determine mortality rates. Additionally, there
may be specific neuronal circuits whose activity must be
maintained above a critical threshold in order to prolong survival.
In this case, even if the overall neurodegenerative effects of the
Ab42 polypeptide in the CNS are greatly ameliorated by reducing
the activity of the TlRNFkB pathway, this might not be sufficient
to substantially increase life span.
It is also possible that reducing the activity of the TlRNFkB
signaling pathway by two-fold (in animals heterozygous for a null
allele) will not be sufficient in itself to strongly suppress the
deleterious effects of the Ab42 polypeptide on life span. One
reason why this might be the case is that neurodegenerative effects
of activating the TlRNFkB signaling pathway in the CNS likely
depend upon triggering other, cell autonomous pathways or
processes after a prolonged or chronic inflammatory response. In
this case, it might be necessary to simultaneously alter the activity
of one or more of these interacting pathways in addition to
TlRNFkB.
Some potential candidates for the participating pathways were
uncovered in our genetic screen for genes that modulate the Ab42
induced rough eye phenotype. For example, we found that a small
deficiency, Df(3)H99, which removes three pro-apoptotic genes
[66], reaper, grim and hid, is a strong suppressor of the rough eye
phenotype. This would suggest that the cell death pathway
promotes the neurodegenerative effects of the human Ab42
polypeptide in the Drosophila eye. Consistent with an induction of
apoptosis, we found that a mutation in croquemort, which is required
for the phagocytosis of apoptotic cells in Drosophila [67],
dominantly enhances the rough eye phenotype. A role for
apoptosis in the degenerative process would also be consistent
with studies on brains of AD patients which have shown that
markers for apoptosis are elevated. In this regard it is interesting to
note that c-Jun N-terminal kinase (JNK) signaling cascade, which
is thought to promote apoptosis, is upregulated in flies by both the
TlRNFkB and IMD innate immunity pathways [56]. Moreover, a
number of observations support a possible role for the JNK
pathway in Ab42 induced neurodegeneration in the fly as well.
First, one of the chromatin modifiers identified in the EP screen
was the histone deacetylase Rpd3 (Hdac1)[27]. Rpd3 histone
deacetylase activity is required to downregulate the JNK pathway
and it functions in complexes with Sin3A and Sap130 [68]. EP
insertions that disrupt the function of Rpd3, Sin3A and Sap130
were found to enhance the rough eye phenotype. Second, we
found that two mutations in pucker (puc), which encodes a tyrosine
phosphatase that antagonizes the JNK kinase enhance the rough
eye phenotype. It has also recently been suggested that activation
of the apoptosis cascade, by JNK, promotes the cleavage and
hyperphosphorylation of Tau [69]. Tau is a microtubule-associated
protein which accumulates in large aggregates in the neurofibrillary
tangles of AD patients [70]. The Tau protein can also have
neurotoxic effects independent of Ab42 [70,71]. The Ab42 induced
rough eye phenotype seems to be connected to the fly tau gene as
well as since we found that it is enhanced by two independent tau
mutations. Further studies will be required to elucidate the role of
these and other genes in modulating the neuropathological effects of
Ab42 and their connection to the functioning of the TlRNFkB
pathway. It will also be important to determine if it is possible to
more substantially ameliorate the life span defects of Ab42 flies by
simultaneously manipulating the activity of the TlRNFkB pathway
and one of these other pathways.
Materials and Methods
Drosophila stocks
All deficiency strains and additional candidate strains were
obtained from the Bloomington stock center (http://flystocks.bio.
indiana.edu). GMR-Ab42 and UAS-Ab42 flies are described in
[25], Tl
3/TM3, dl
4/Cyo, dl
8/Cyo, hsp83dl/TM3 were gifts from Dr.
Govind and Dr. Steward and Dif
1 is a gift from Dr. Wu.
Screen for dominant suppressors and enhancers
GMR-Ab42/Ubx virgin females were used for crosses to males
from different deficiencies and candidates strains. Crosses were
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before being scored for eye phonotype. On average, 50–100 flies
that are trans-heterozygote for a deletion or candidate mutant and
one copy of GMR-Ab42 transgene were scored simultaneously and
were compared to their similarly aged siblings who only had one
copy of the GMR-Ab42 transgene. The suppression/enhancement
of the rough eye phenotype was characterized into weak, moderate
or strong categories as indicated in the tables.
Protein analysis
Protein was extracted from fly heads (10–15 heads pooled
sample) with sample buffer for Western analysis. Anti-cactus
(mouse monoclonal, gift from Dr. Steward, anti-SNF (mouse
monoclonal antibody, DSHB, http://dshb.biology.uiowa.edu/)
were used. Experimental samples were always compared to
control samples of the same age. To account for difference seen
among flies with same genotype, we also carried out the Western
blot analysis with protein sample extracted from a single fly head.
Survival Assay
Twenty to 30 young flies were placed in a food vial. Each vial
was kept at 29uC. Food vials were changed every 4–5 days, and
the dead flies were counted at that time. At least 50 flies were
prepared for each genotype, and the experiments were carried out
more than three times.
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